Premium
Amelogenin Enhances the Proliferation of Cementoblast Lineage Cells
Author(s) -
Kunimatsu Ryo,
Tanimoto Kotaro,
Tanne Yuki,
Kamiya Takashi,
Ohkuma Satoru,
Huang YuChing,
Yoshimi Yuki,
Miyauchi Mutsumi,
Takata Takashi,
Tanne Kazuo
Publication year - 2011
Publication title -
journal of periodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.036
H-Index - 156
eISSN - 1943-3670
pISSN - 0022-3492
DOI - 10.1902/jop.2011.110031
Subject(s) - amelogenin , cementoblast , cementum , chemistry , extracellular matrix , microbiology and biotechnology , western blot , kinase , cell growth , mapk/erk pathway , biology , biochemistry , dentistry , medicine , dentin , gene
Background: It is well known that enamel matrix proteins play a crucial role in tooth root formation and amelogenesis. Because amelogenin is a major enamel matrix protein, it is assumed that amelogenin also affects the metabolism of cementum. However, the biologic functions of amelogenin in cementoblasts remain unclear. The purpose of this study is to examine the effect of recombinant human full‐length amelogenin (rh174) on the proliferation of cultured human cementoblast‐like (HCEM) and human periodontal ligament (HPDL) cells. Methods: HCEM and HPDL cells were cultured and treated with 100 ng/mL rh174 in the presence or absence of an anti‐cluster of differentiation (CD) 63 blocking antibody. Cell proliferation was evaluated using a cell proliferation enzyme‐linked immunosorbent assay 5‐bromo‐2‐deoxyuridine kit and quantification of the cell number by 3‐(4, 5‐dimethylthiazol‐2‐yl)‐5‐(3‐carboxymethoxyphenyl)‐2‐(4‐sulfophenyl)‐2 H‐tetrazolium‐inner salt assay. The phosphorylation of extracellular signal‐regulated kinases (ERK) 1/2 was measured by enzyme‐linked immunosorbent assay and Western blot analysis. Results: The proliferation of HCEM and HPDL cells was enhanced significantly ( P <0.05) by treatment with rh174, and inhibited significantly ( P <0.05) by the addition of anti‐CD63 blocking antibody. In addition, the ratio of phosphorylated ERK1/2 to total ERK1/2 became significantly larger ( P <0.05) by treatment with rh174, and was reduced significantly by the addition of anti‐CD63 blocking antibody in both HCEM and HPDL cells. Conclusion: The results show that rh174 interacts with CD63, and rh174/CD63 interaction activates the ERK1/2 signaling pathway, enhancing the proliferation activities of HCEM and HPDL cells.